Clinical and neurohormonal correlates and prognostic value of serum prolactin levels in patients with chronic heart failure

European Journal of Heart Failure

Volumn 15, Issue 10, 2013, Pages 1122-1130

  Parissis, John T ^a   Farmakis, Dimitrios ^a   Fountoulaki, Katerina ^a   Rigas, Antonios ^a   Nikolaou, Maria ^a   Paraskevaidis, Ioannis A ^a   Bistola, Vassiliki ^a   Venetsanou, Koula ^a   Ikonomidis, Ignatios ^a   Anastasiou Nana, Maria ^a   Kremastinos, Dimitrios T ^a   Filippatos, Gerasimos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cytokines; Depression; Heart failure; Prognosis; Prolactin

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; NATRIURETIC FACTOR; NEUROHORMONE; PROLACTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; CAUSE OF DEATH; DEPRESSION; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROGNOSIS; PROLACTIN BLOOD LEVEL; WALKING; ZUNG SELF RATING DEPRESSION SCALE;

CYTOKINES; DEPRESSION; HEART FAILURE; PROGNOSIS; PROLACTIN;

AGED; CHRONIC DISEASE; CYTOKINES; DEPRESSION; EXERCISE TEST; FAS LIGAND PROTEIN; FEMALE; HEART FAILURE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PITUITARY-ADRENAL SYSTEM; PROGNOSIS; PROLACTIN; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885053755     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft070     Document Type: Article

References (34)

1. York M, Hasan M, Sheps D. Psychobiology of depression/distress in congestive heart failure. Heart Fail Rev 2009;14:35-50.
2. Dantzer R. Cytokine, sickness behavior and depression. Neurol Clin 2006;24: 441-460.
3. Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, Rothermundt M. Different activation patterns of pro-inflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 2005;87:305-311. (Pubitemid 41039953)
4. Ferketich AK, Ferguson JP, Binkley PF. Depressive symptoms and inflammation among heart failure patients. Am Heart J 2005;150:132-136. (Pubitemid 41097440)
5. Corbacho AM, Martinez de la Escalera G, Clapp C. Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 2002;173:219-238. (Pubitemid 34552451)
6. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368:687-693. (Pubitemid 44223695)
7. Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, Becker A, Yip A, Klein G, Sliwa K. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartumcardiomyopathy. Eur J Heart Fail 2008;10:861-868.
8. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92:631-642.
9. Zung WWK, Richards CB, Short MJ. Self-rating depression scale in an outpatient clinic. Arch Gen Psychiatry 1965;13:508-515.
10. Parissis JT, Nikolaou M, Farmakis D, Bistola V, Paraskevaidis IA, Adamopoulos S, Filippatos G, Kremastinos DT. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart 2008;94:585-589. (Pubitemid 351580132)
11. Pencina MJ, D'Agostino RB Sr, SteyerbergEW. Extensions of net reclassification improvement calculations to measure usefulness ofnewbiomarkers. StatMed2011;30: 11-21.
12. Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation 1999;100:999-1008. (Pubitemid 29407182)
13. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of pro-inflammatory cytokines. Chest 1994;105:897-904. (Pubitemid 24088479)
14. Anker SD, von Haehling S. Inflammatory mediators in chronic heart failure: an overview. Heart 2004;90:464-470. (Pubitemid 38406929)
15. Adamopoulos S, Parissis J, Kremastinos D. A glossary of circulating cytokines in chronic heart failure. Eur J Heart Fail 2001;3:517-526. (Pubitemid 34619192)
16. Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996;2:243-249.
17. von Haehling S, Jankowska EA, Anker SD. Tumour necrosis factor-alpha and the failing heart: pathophysiology and therapeutic implications. Basic Res Cardiol 2004; 99:18-28. (Pubitemid 38049136)
18. Adamopoulos S, Parissis J, Kremastinos D. Endothelial dysfunction in chronic heart failure: clinical and therapeutic implications. Eur J Intern Med 2002;13:233-239. (Pubitemid 34627052)
19. Parissis JT, Adamopoulos S, Rigas A, Kostakis G, Karatzas D, Venetsanou K, Kremastinos DT. Comparison of circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am J Cardiol 2004;94:1326-1328. (Pubitemid 39469963)
20. Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom Med 2003;65:181-193. (Pubitemid 36359329)
21. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 1995;57:1011-1026.
22. Kang YM, Zhang ZH, Xue B,Weiss RM, Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 2008;295:H227-H236.
23. Kang YM,HeRL, YangLM, QinDN,Guggilam A, Elks C, YanN,GuoZ, Francis J. Brain tumour necrosis factor-alpha modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc Res 2009;83:737-746.
24. Hilfiker-Kleiner D, Schieffer E, Meyer GP, Podewski E, Drexler H. Postpartum cardiomyopathy: a cardiac emergency for gynecologists, general practitioners, internists, pulmonologists, and cardiologists. Dtsch Arztebl Int 2008;105:751-756.
25. Jara LJ, Medina G, Saavedra MA, Vera-Lastra O, Navarro C. Prolactin and autoimmunity. Clin Rev Allergy Immunol 2011;40:50-59.
26. Corbacho AM, Martinez De La Escalera G, Clapp C. Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 2002;173:219-238. (Pubitemid 34552451)
27. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589-600. (Pubitemid 46206082)
28. Tabruyn SP, Sorlet CM, Rentier-Delrue F, Bours V,Weiner RI, Martial JA, Struman I. The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB. Mol Endocrinol 2003;7:1815-1823. (Pubitemid 37072297)
29. Ntusi NB, Mayosi BM. Aetiology and risk factors of peripartum cardiomyopathy: a systematic review. Int J Cardiol 2009;131:168-179.
30. Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Hilfiker-Kleiner D. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010;121:1465-1473.
31. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ; Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge onaetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12:767-778.
32. Metra M, Ponikowski P, Dickstein K, McMurray JJ, Gavazzi A, Bergh CH, Fraser AG, Jaarsma T, Pitsis A, Mohacsi P, BöhmM, Anker S, Dargie H, Brutsaert D, Komajda M; Heart Failure Association of the European Society of Cardiology. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2007;9:684-694. (Pubitemid 46705572)
33. Landberg E, DahlströmU, Alehagen U. Serum prolactin and macroprolactin in heart failure: no relation to established laboratory or clinical parameters. Ann Clin Biochem 2011;48:51-56.
34. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis Treatment of Acute Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, MuellerC, Nanas JN, NielsenOW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.